TLDR Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.
The document presents a case report of a 6-year-old girl with severe alopecia areata (AA), a common autoimmune disease characterized by non-scarring hair loss, who was effectively treated using oral tofacitinib therapy. The girl experienced more than 90% hair regrowth after 3 months of treatment and complete regrowth after 6 months, with no relapse observed after dose reduction. The document also reviews global cases where tofacitinib was used to treat pediatric AA, indicating that it usually leads to hair growth within the first 3 months and significant regrowth after 6 months of continued therapy. The document concludes that oral tofacitinib could be a potential treatment for children with AA in the future, but further research is needed to investigate its maximum effect, possibility of relapse after cessation of therapy, maintenance measures, and long-term impact.
7 citations,
March 2021 in “Journal of the American Academy of Dermatology” Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.
39 citations,
January 2019 in “Journal of the American Academy of Dermatology” Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.
40 citations,
September 2018 in “Journal of the American Academy of Dermatology” Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.
49 citations,
March 2017 in “Journal of the American Academy of Dermatology” Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.
355 citations,
January 2017 in “Journal of the American Academy of Dermatology” JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.
701 citations,
August 2014 in “Nature medicine” Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.
391 citations,
January 2010 in “Journal of The American Academy of Dermatology” Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.
1 citations,
September 2022 in “International Journal of Trichology” Tofacitinib can be effective in treating hair loss caused by alopecia areata.
4 citations,
July 2018 in “PubMed” Oral and topical tofacitinib can help regrow hair in people with severe alopecia areata.
January 2014 in “DOAJ (DOAJ: Directory of Open Access Journals)” Minoxidil can effectively treat patchy hair loss by stimulating hair growth.
